Steven St. Peter

Steven St. Peter

Founder bij Vie Venture LLC

57 jaar
Health Technology
Finance
Consumer Services

Profiel

Steven St. Peter joined the T1D Fund in November 2019.
From 2012 until 2019, Steven was Founder, President and Chief Executive Officer of Aratana Therapeutics, Inc. (NASDAQ: PETX), an animal health company focused on the licensing, development and commercialization of innovative therapeutics.
Steven was previously a Managing Director at MPM Capital in Boston where his investment scope included both venture and buyout transactions across the pharmaceutical and medical technology industries.
His investment experience also includes positions at Apax Partners and The Carlyle Group.
Over the past decades, Steven has founded, invested in and/or been involved with several life sciences companies including Align Technologies (NASDAQ: ALGN), Medpointe, ESP Pharma, SkinMedica, Omrix (NASDAQ: OMRI), Pharmathene (NYSE: PIP), Xanodyne, Syndax (NASDAQ: SNDX), EKR Therapeutics, Proteon (NASDAQ: PRTO), Rhythm (NASDAQ:RYTM) and others.
Steven has served on the Executive Committee & Board of Directors of the New England Venture Capital Association and he has been active in a variety of other professional organizations.
Previously, Steven was Assistant Clinical Professor of Medicine at Columbia University.
He received his M.D.
from Washington University and completed his residency and fellowship at the Hospital of the University of Pennsylvania.
He also holds an M.B.A.
in Finance from the Wharton School of the University of Pennsylvania and a B.A.
in Chemistry from the University of Kansas.

Actieve functies van Steven St. Peter

BedrijvenFunctieBegin
Kansas City Area Life Sciences Institute, Inc. Director/Board Member 01-03-2014
Founder 01-05-2012
Director/Board Member 01-11-2015
Private Equity Investor 01-11-2019
Alle actieve functies van Steven St. Peter

Eerdere bekende functies van Steven St. Peter

BedrijvenFunctieEinde
Chairman 01-06-2020
ARATANA THERAPEUTICS INC Founder 17-01-2019
Director/Board Member 03-10-2012
Director/Board Member -
SYNDAX PHARMACEUTICALS, INC. Director/Board Member 16-05-2012
Ervaring van Steven St. Peter in detail bekijken

Opleiding van Steven St. Peter

University of Washington Doctorate Degree
University of Kansas Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Steven St. Peter in detail bekijken

Connecties

100 +

Eerstegraads connecties

26

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
SYNDAX PHARMACEUTICALS, INC.

Health Technology

RHYTHM PHARMACEUTICALS, INC.

Health Technology

Bedrijven in privébezit21

Finance

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Finance

Finance

Commercial Services

Health Technology

Miscellaneous

Health Technology

Commercial Services

Kansas City Area Life Sciences Institute, Inc.

Health Technology

Health Technology

Finance

Health Technology

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Steven St. Peter